Results 41 to 50 of about 167,693 (338)
Signal Transduction and Targeted Therapy, 2020 Dear Editor, Corona Virus Disease 2019 (COVID-19) was first reported in late December 2019, in Wuhan, China. There are over 1,800,000 confirmed cases worldwide.1 The pathological process of severe COVID-19 pneumonia is an inflammation reaction ...
Yin Wang +7 more
semanticscholar +1 more source
Ofatumumab and high-dose methylprednisolone for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia. [PDF]
, 2014 Ofatumumab is a humanized anti-CD20 monoclonal antibody that has been approved by the FDA for the treatment of patients with chronic lymphocytic leukemia. We conducted a phase II single-arm study at a single center.
Almahasnah, E +6 more
core +3 more sources
Frontiers in Microbiology, 2022 The WHO announced coronavirus disease 2019 (COVID-19) as a pandemic disease globally on March 11, 2020, after it emerged in China. The emergence of COVID-19 has lasted over a year, and despite promising vaccine reports that have been produced, we still ...
Jyoti Mehta +5 more
doaj +1 more source
Steroid induced osteonecrosis: An analysis of steroid dosing risk. [PDF]
, 2010 Osteonecrosis is a serious condition involving bone destruction that frequently requires surgical treatment to rebuild the joint. While there is an abundance of literature documenting corticosteroid related osteonecrosis, there is no consensus as to the ...
Chang, Christopher +4 more
core +1 more source
High Dose Methylprednisolone versus Low Dose in Correction of Congenital Acyanotic Heart Disease
Egyptian Journal of Anaesthesia, 2022 Background A large number of pediatric patients undergoing congenital heart disease corrective procedures receive peri-operative corticosteroids, aiming to reduce post-operative inflammation and capillary leak following cardiopulmonary bypass (CPB). This
Maha Sadek El Derh +2 more
doaj +1 more source
GLUCOCOVID: A controlled trial of methylprednisolone in adults hospitalized with COVID-19 pneumonia
medRxiv, 2020 Background. We aimed to determine whether a 6-day course of intravenous methylprednisolone (MP) improves outcome in patients with SARS CoV-2 infection at risk of developing Acute Respiratory Distress Syndrome (ARDS). Methods.
Luis Corral +16 more
semanticscholar +1 more source
High‐dose methylprednisolone in nonintubated patients with severe COVID‐19 pneumonia
European Journal of Clinical Investigation, 2020 Recent trials with dexamethasone and hydrocortisone have demonstrated benefit in patients with coronavirus disease 2019 (COVID‐19). Data on methylprednisolone are limited.
A. Papamanoli +10 more
semanticscholar +1 more source
Frontiers in Surgery, 2022 BackgroundThe analgesic effect produced by the intra-arterial injection of lidocaine in patients undergoing uterine artery embolization has been proven to be safe and effective.
Yi Tang +20 more
doaj +1 more source
Clinical Infectious Diseases, 2020 Background The efficacy and safety of methylprednisolone in mechanically ventilated patients with acute respiratory distress syndrome due to coronavirus disease 2019 (COVID-19) are unclear.
B. Nelson +8 more
semanticscholar +1 more source
Eosinophilic granulomatosis with polyangiitis (EGPA) and PRES: a case-based review of literature in ANCA-associated vasculitides [PDF]
, 2015 Eosinophilic granulomatosis with polyangiitis (EGPA) is a small-sized vessel systemic necrotizing vasculitis and belongs to the family of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides.
Barilaro, Giuseppe +3 more
core +1 more source